Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format
May 18 2021 - 6:00AM
Business Wire
Big Bag o’ Buds strains include both
celebrated and new cultivars, including Organigram’s
industry-leading Ultra Sour
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a
leading licensed producer of cannabis, is pleased to announce the
launch of Big Bag o’ Buds, a lineup of dried flower products
featuring a roster of well-known genetics and an exciting rotation
of one-time offerings (OTO) in a 28g format.
“Customers across the country continue to express the importance
of large formats and new genetic offerings at an appealing price
point,” says Tim Emberg, Senior Vice President of Sales and
Commercial Operations at Organigram. “Without a doubt, Big Bag o’
Buds delivers on all of those points but also offers Canadian
consumers a continuous pipeline of new cultivars reflecting our
team’s ongoing search for and development of new terpene profiles
and phenotypic expressions.”
Big Bag o’ Buds offers a minimum of 17% THC and a rich cultivar
selection that includes Ultra Sour, a pungent, sativa-leaning sour
featuring the tartness of Meyer lemon and the diesel and pungent
notes from the cultivar’s Kush undertones. Organigram currently
leads the pack with the #1 Ultra Sour brand in Canada. The Big Bag
o’ Buds OTO cultivar selection will include Grapefruit GG4,
Original Glue, and Lemon Tree strains.
Every Big Bag o’ Buds strain benefits from being grown in
strain-specific, climate-controlled indoor grow rooms to optimize
each cultivar’s flavour. Variables including humidity, temperature,
light and plant density can be customized to enhance the growth and
output of each plant.
Big Bag o’ Buds is available at select retailers across
Canada.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc., a licensed producer of cannabis and
cannabis-derived products in Canada and The Edibles and Infusions
Corporation, a cannabis infused soft chew and confectionary
manufacturer in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and
Trailblazer. Organigram's facility is located in Moncton, New
Brunswick with another leased manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210518005386/en/
For Investor Relations enquiries: Amy Schwalm Vice
President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057 For Media enquiries: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024